To determine whether a continuous i.v. infusion of cimetidine , a histamine-2 ( H2 ) receptor antagonist , is needed to prevent upper gastrointestinal ( GI ) hemorrhage when compared with placebo and if that usage is associated with an increased risk of nosocomial pneumonia .
